Searcey M - Search Results

1

Polyclonal antibody-catalysed amide hydrolysis.

Gallacher G, Searcey M, Jackson CS, Brocklehurst K. Gallacher G, et al. Among authors: searcey m. Biochem J. 1992 Jun 15;284 ( Pt 3)(Pt 3):675-80. doi: 10.1042/bj2840675. Biochem J. 1992. PMID: 1622388 Free PMC article.

2

A polyclonal antibody preparation with Michaelian catalytic properties.

Gallacher G, Jackson CS, Searcey M, Badman GT, Goel R, Topham CM, Mellor GW, Brocklehurst K. Gallacher G, et al. Among authors: searcey m. Biochem J. 1991 Nov 1;279 ( Pt 3)(Pt 3):871-81. doi: 10.1042/bj2790871. Biochem J. 1991. PMID: 1953683 Free PMC article.

3

Polyclonal-antibody-catalysed hydrolysis of an aryl nitrophenyl carbonate.

Gallacher G, Jackson CS, Topham CM, Searcey M, Turner BC, Badman GT, Brocklehurst K. Gallacher G, et al. Among authors: searcey m. Biochem Soc Trans. 1990 Aug;18(4):600-1. doi: 10.1042/bst0180600. Biochem Soc Trans. 1990. PMID: 2276458 No abstract available.

4

Catalytic antibody activity elicited by active immunisation. Evidence for natural variation involving preferential stabilization of the transition state.

Gallacher G, Jackson CS, Searcey M, Goel R, Mellor GW, Smith CZ, Brocklehurst K. Gallacher G, et al. Among authors: searcey m. Eur J Biochem. 1993 May 15;214(1):197-207. doi: 10.1111/j.1432-1033.1993.tb17913.x. Eur J Biochem. 1993. PMID: 8508792 Free article.

5

Advances in triterpene drug discovery.

Goddard ZR, Searcey M, Osbourn A. Goddard ZR, et al. Among authors: searcey m. Trends Pharmacol Sci. 2024 Nov;45(11):964-968. doi: 10.1016/j.tips.2024.10.003. Epub 2024 Oct 30. Trends Pharmacol Sci. 2024. PMID: 39482199 Free article. Review.

6

IS4-FAM, a fluorescent tool to study CXCR4 affinity and competitive antagonism in native cancer cells.

Hamshaw I, Cominetti MMD, Nana-Akyin P, Yee Ho EH, Searcey M, Mueller A. Hamshaw I, et al. Among authors: searcey m. Pharmacol Res Perspect. 2024 Oct;12(5):e70003. doi: 10.1002/prp2.70003. Pharmacol Res Perspect. 2024. PMID: 39207051 Free PMC article.

7

Light-activated azobenzene peptide inhibitor of the PD-1/PD-L1 interaction.

Hayward D, Goddard ZR, Cominetti MMD, Searcey M, Beekman AM. Hayward D, et al. Among authors: searcey m. Chem Commun (Camb). 2024 Aug 1;60(63):8228-8231. doi: 10.1039/d4cc01249f. Chem Commun (Camb). 2024. PMID: 39007209 Free PMC article.

8

Borylation via iridium catalysed C-H activation: a new concise route to duocarmycin derivatives.

Cominetti MMD, Goddard ZR, Hood BR, Beekman AM, O'Connell MA, Searcey M. Cominetti MMD, et al. Among authors: searcey m. Org Biomol Chem. 2024 Jul 10;22(27):5603-5607. doi: 10.1039/d4ob00814f. Org Biomol Chem. 2024. PMID: 38904084 Free PMC article.

9

Suramin: Effectiveness of analogues reveals structural features that are important for the potent trypanocidal activity of the drug.

Steverding D, Tinson RAJ, Piras M, Wren SP, Rushworth SA, Searcey M, Troeberg L. Steverding D, et al. Among authors: searcey m. Exp Parasitol. 2024 May;260:108744. doi: 10.1016/j.exppara.2024.108744. Epub 2024 Mar 19. Exp Parasitol. 2024. PMID: 38513971 Free article.

10

The development of potent, competitive CXCR4 antagonists for the prevention of cancer metastasis.

Hamshaw I, Cominetti MMD, Lai WY, Searcey M, Mueller A. Hamshaw I, et al. Among authors: searcey m. Biochem Pharmacol. 2023 Dec;218:115921. doi: 10.1016/j.bcp.2023.115921. Epub 2023 Nov 11. Biochem Pharmacol. 2023. PMID: 37956893 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters